Cargando…
Copy Number Variation Analysis in Familial BRCA1/2-Negative Finnish Breast and Ovarian Cancer
BACKGROUND: Inherited factors predisposing individuals to breast and ovarian cancer are largely unidentified in a majority of families with hereditary breast and ovarian cancer (HBOC). We aimed to identify germline copy number variations (CNVs) contributing to HBOC susceptibility in the Finnish popu...
Autores principales: | Kuusisto, Kirsi M., Akinrinade, Oyediran, Vihinen, Mauno, Kankuri-Tammilehto, Minna, Laasanen, Satu-Leena, Schleutker, Johanna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3742470/ https://www.ncbi.nlm.nih.gov/pubmed/23967248 http://dx.doi.org/10.1371/journal.pone.0071802 |
Ejemplares similares
-
Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals
por: Kuusisto, Kirsi M, et al.
Publicado: (2011) -
Germline EMSY sequence alterations in hereditary breast cancer and ovarian cancer families
por: Määttä, Kirsi M., et al.
Publicado: (2017) -
Genetic, clinic and histopathologic characterization of BRCA-associated hereditary breast and ovarian cancer in southwestern Finland
por: Pallonen, Terhi Aino-Sofia, et al.
Publicado: (2022) -
Neurocognitive follow‐up in adult siblings with Phelan–McDermid syndrome due to a novel SHANK3 splicing site mutation
por: Kankuri‐Tammilehto, Minna, et al.
Publicado: (2021) -
DNA copy number profiling reveals extensive genomic loss in hereditary BRCA1 and BRCA2 ovarian carcinomas
por: Kamieniak, M M, et al.
Publicado: (2013)